Two-Year Exercise Program Improved Bone Measures in T2DM Read more about Two-Year Exercise Program Improved Bone Measures in T2DM
AACE 2026: IDA May Distort A1C Readings in Stroke Patients With T2DM Tags Hypoglycemia Stroke hBA1c Read more about AACE 2026: IDA May Distort A1C Readings in Stroke Patients With T2DM
AACE 2026: Common AEs Seen With Teplizumab in Stage 2 and 3 T1DM Read more about AACE 2026: Common AEs Seen With Teplizumab in Stage 2 and 3 T1DM
ACC.26: AF Rates Were Lower Among GLP-1 Users With Advanced CKD Tags Atrial Fibrillation SGLT-2 Inhibitor Read more about ACC.26: AF Rates Were Lower Among GLP-1 Users With Advanced CKD
GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy Tags Diabetic Nephropathy Retinopathy Read more about Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
LOPS Signals Higher Burden of Diabetic Foot Complications Over Time Tags Diabetic foot. Read more about LOPS Signals Higher Burden of Diabetic Foot Complications Over Time
AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin
Higher HbA1c Threshold May Better Stratify Adult T1DM Risk Tags hBA1c Read more about Higher HbA1c Threshold May Better Stratify Adult T1DM Risk
